ATE430937T1 - Plasma urotensin und menschliche herzerkrankung - Google Patents

Plasma urotensin und menschliche herzerkrankung

Info

Publication number
ATE430937T1
ATE430937T1 AT03740791T AT03740791T ATE430937T1 AT E430937 T1 ATE430937 T1 AT E430937T1 AT 03740791 T AT03740791 T AT 03740791T AT 03740791 T AT03740791 T AT 03740791T AT E430937 T1 ATE430937 T1 AT E430937T1
Authority
AT
Austria
Prior art keywords
heart disease
human heart
urotensin
plasma
plasma urotensin
Prior art date
Application number
AT03740791T
Other languages
English (en)
Inventor
Leong Ng
Original Assignee
Inverness Medical Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216505A external-priority patent/GB0216505D0/en
Application filed by Inverness Medical Switzerland filed Critical Inverness Medical Switzerland
Application granted granted Critical
Publication of ATE430937T1 publication Critical patent/ATE430937T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5751—Corticotropin releasing factor [CRF] (Urotensin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03740791T 2002-07-11 2003-07-11 Plasma urotensin und menschliche herzerkrankung ATE430937T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0216191.7A GB0216191D0 (en) 2002-07-11 2002-07-11 Plasma urotensin in human heart failure
GBGB0216500.9A GB0216500D0 (en) 2002-07-11 2002-07-16 Plasma urotensin in human heart failure
GB0216505A GB0216505D0 (en) 2002-07-11 2002-07-17 Plasma urotensin in human heart failure
PCT/GB2003/003011 WO2004008140A2 (en) 2002-07-11 2003-07-11 Plasma urotensin in human heart failure

Publications (1)

Publication Number Publication Date
ATE430937T1 true ATE430937T1 (de) 2009-05-15

Family

ID=9940317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740791T ATE430937T1 (de) 2002-07-11 2003-07-11 Plasma urotensin und menschliche herzerkrankung

Country Status (11)

Country Link
US (1) US20040077027A1 (de)
EP (1) EP1521967B1 (de)
JP (1) JP4602078B2 (de)
CN (1) CN100582782C (de)
AT (1) ATE430937T1 (de)
AU (1) AU2003281071B2 (de)
CA (1) CA2492787A1 (de)
DE (1) DE60327530D1 (de)
GB (2) GB0216191D0 (de)
IL (2) IL166194A0 (de)
WO (1) WO2004008140A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
WO2006123253A2 (en) * 2005-03-29 2006-11-23 Inverness Medical Switzerland Gmbh Device and method of monitoring a patient
EP1722232A1 (de) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion
EP1910843A2 (de) * 2005-07-11 2008-04-16 Inverness Medical Switzerland GmbH Assay
DK2115477T3 (en) * 2007-01-25 2015-08-10 Hoffmann La Roche USE OF IGFBP-7 IN THE EVIDENCE OF HEART FAILURE
CA2680339C (en) * 2007-03-08 2017-02-28 F. Hoffmann-La Roche Ag Use of slim-1 in the assessment of heart failure
EP2347265A1 (de) * 2008-10-17 2011-07-27 Roche Diagnostics GmbH Verwendung von biglycan bei der beurteilung von herzversagen
WO2015175502A2 (en) * 2014-05-12 2015-11-19 Palatin Technologies, Inc. Replacement therapy for natriuretic peptide deficiencies
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
EP4767065A1 (de) * 2023-08-22 2026-07-01 Roche Diagnostics GmbH Überwachung von kardiovaskulären markern in interstitieller flüssigkeit und ihre anwendung bei der beurteilung von herzversagen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
US5710008B1 (en) * 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US6210976B1 (en) * 1997-06-10 2001-04-03 Medlyte Diagnostics, Inc. Methods for early detection of heart disease
US6075137A (en) * 1998-01-09 2000-06-13 Smithkline Beecham Corporation Human urotensin II
EP1045908A2 (de) * 1998-01-09 2000-10-25 Smithkline Beecham Corporation Menschliches urotensin ii
ATE373826T1 (de) * 1999-01-29 2007-10-15 Roche Diagnostics Gmbh Verfahren zum nachweis von n-terminalem probnp
EP1241479B1 (de) * 2001-03-12 2007-08-01 Immundiagnostik AG Verfahren zur Bestimmung von Urotensin II in Körperflüssigkeiten und Diagnose von kardiovaskulären Krankheiten

Also Published As

Publication number Publication date
AU2003281071A1 (en) 2004-02-02
IL166194A (en) 2010-11-30
US20040077027A1 (en) 2004-04-22
EP1521967A2 (de) 2005-04-13
EP1521967B1 (de) 2009-05-06
IL166194A0 (en) 2006-01-15
CN1678912A (zh) 2005-10-05
CN100582782C (zh) 2010-01-20
JP2005532564A (ja) 2005-10-27
JP4602078B2 (ja) 2010-12-22
WO2004008140A3 (en) 2004-05-06
WO2004008140A2 (en) 2004-01-22
DE60327530D1 (de) 2009-06-18
GB0216500D0 (en) 2002-08-28
GB0216191D0 (en) 2002-08-21
CA2492787A1 (en) 2004-01-22
AU2003281071B2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
DE60327530D1 (de) Plasma urotensin und menschliche herzerkrankung
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
DE60326214D1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
DK1530724T3 (da) Diagnose og forebyggelse af cancercelleinvasion
ATE468811T1 (de) Verfahren und system zur überwachung von beatmungen
DE60302995D1 (de) Blutdruckmessgerät
DE50200029D1 (de) Medizinisches Instrument zum Spülen und/oder Saugen
FI20030547A0 (fi) Menetelmä ja järjestelmä sydänanalyysiä varten
SE0301825D0 (sv) Method and arrangement relating to testing implants
EP1962946A4 (de) Verfahren und vorrichtung zur bestimmung der herzleistung in einem patienten
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
FI20020584A7 (fi) Menetelmä havainnointialueen mittakaavan määrittämiseksi
FI20031678A0 (fi) Näytteen käsittelymenetelmä ja järjestely siihen
EP1816211A4 (de) Verfahren zum nachweis von blutplättchenthrombose oder organversagen
EP1539957A4 (de) Neue diagnose- und therapieverfahren und reagentien dafür
EP1540353A4 (de) Teststreifen und verfahren zur bestimmung der ldl-cholesterinkonzentration aus vollblut
EP1483407A4 (de) Therapie- und diagnoseverfahren
ATE498020T1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
EP1492880A4 (de) Ex-vivo-verfahren zur bestimmung der cetp-aktivität und der wirksamkeit der behandlung von herzerkrankungen
ITMI20022743A1 (it) Metodo per la determinazione del rischio di comparsa, della presenza o del decorso di malattie tumorali.
EP1567863A4 (de) Therapie- und diagnoseverfahren
ATE483983T1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
WO2002053769A3 (de) Dna-chip zur kausalen diagnose von bluthochdruck

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties